NEW YORK (GenomeWeb News) – Molecular Detection and Palex Medical today announced an exclusive agreement, under which Palex will distribute MDI's Detect-Ready MRSA test in Spain.
Palex, a Spanish distributor of medical devices and diagnostic products, recently launched the test in Spain, the companies said in a statement. Financial terms of the deal were not announced.
The Detect-Ready test is a real-time PCR in vitro diagnostic test for the direct detection of methicilllin-resistant Staphylococcus aureus nasal colonization. Unlike other MRSA tests, the Detect-Ready kit are off-the-shelf, room-temperature-stabilized, and require no refrigeration, the two firms said. It also is compatible with several real-time PCR platforms.
In May, MDI and Launch Diagnostics announced a distribution agreement for the test in the UK, France, and Republic or Ireland. The test is also available in Germany, Switzerland, and Austria.
Last month, MDI said it had raised $1.4 million in a follow on to a Series C round of financing.